416 results match your criteria: "Breast Reconstruction Expander-Implant"
Ann Plast Surg
December 2024
From the Division of Plastic Surgery, Department of Surgery, University of Rochester, Rochester, NY.
Purpose: The use of "mesh" in implant-based reconstruction is widespread, with both acellular dermal matrices (ADMs) and extracellular matrices (ECMs) being used, especially in prepectoral device placement. This study compared Ovitex (ovine ECM) versus human cadaveric ADMs to determine safety profiles and cost-effectiveness.
Methods: A single surgeon's longitudinal experience with 2-stage, immediate tissue expander breast reconstruction from 2018 to 2023 was analyzed.
Surg Infect (Larchmt)
November 2024
Division of Breast Surgery, Department of General Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Most studies on surgical site infections (SSIs) use the US Centers for Disease Control and Prevention (CDC) guidelines, which excludes inflammation or cellulitis without fever. The aim of this study was to evaluate antibiotic prescription trends in the post-operative period among patients undergoing breast operation. We explore the outcomes of patients receiving antibiotic agents outside of the CDC-defined SSI.
View Article and Find Full Text PDFEplasty
October 2024
Division of Plastic and Reconstructive Surgery, Stanford University School of Medicine, Stanford, California.
Background: Human acellular dermal matrices (ADMs) remain the most used matrices in prosthetic breast reconstruction. However, the availability and cost of ADMs limit their use in prepectoral reconstruction-which requires large amounts of ADM-and alternative matrices are therefore being explored.
Objectives: The aim of this study was to demonstrate the safety and efficacy of human-porcine ADM constructs via clinical outcomes and histologic evidence of graft integration.
Plast Reconstr Surg Glob Open
September 2024
From the Division of Plastic and Reconstructive Surgery, Mayo Clinic, Rochester, Minn.
Background: Limited studies have detailed the risk of mastectomy with immediate breast reconstruction among women who previously received mantle field radiation.
Methods: A single institution retrospective review from 2010 to 2020 of patients previously treated with mantle field radiation (MF-RT) and subsequent mastectomy with immediate breast reconstruction was performed. Patients with prior whole breast irradiation (WBI) were also included as a reference group.
J Plast Surg Hand Surg
May 2024
Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden; Sophiahemmet Hospital, Stockholm, Sweden.
Radiotherapy is important in breast cancer treatment. A side effect of the treatment is fibrosis that decreases the possibility for a successful breast reconstruction with expanders and with high patient satisfaction with the result. The most common option for mastectomized, irradiated women wishing for a breast reconstruction is autologous tissue transplantation.
View Article and Find Full Text PDFGland Surg
December 2023
National Center for Plastic Surgery, McLean, VA, USA.
Breast cancer remains the most commonly diagnosed cancer in women in the United States. In the setting of a mastectomy, implant-based reconstruction (IBR) remains the most common type of breast reconstruction performed. IBR is typically performed in two-stages (tissue expander - implant) or one stage [direct-to-implant (DTI)].
View Article and Find Full Text PDFJ Clin Med
October 2023
Department of Radiation Oncology, Far Eastern Memorial Hospital, New Taipei 220216, Taiwan.
Background: The target volume for post-mastectomy radiation therapy (PMRT) in breast cancer patients with reconstruction has been a subject of debate. Traditionally, the RT chest wall (CW) volume encompasses the entire implant. For patients with retropectoral implants, the deep lymphatic plexus dorsal part of the implant is no longer considered high risk and can be omitted.
View Article and Find Full Text PDFJ Plast Reconstr Aesthet Surg
December 2023
Department of Plastic Surgery and Burns Treatment, Copenhagen University Hospital, Denmark; Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. Electronic address:
J Plast Reconstr Aesthet Surg
November 2023
Division of Plastic and Reconstructive Surgery, Stanford University School of Medicine, Stanford, CA, USA. Electronic address:
Background: Fat grafting is commonly undertaken as a third-stage procedure in patients with staged implant-based breast reconstruction (IBR). However, fat grafting performed during second-stage expander/implant exchange provides faster results without an additional procedure and associated risks (Patel et al., 2020).
View Article and Find Full Text PDFBr J Surg
November 2023
Translational Health Sciences, Bristol Medical School, Bristol, UK.
Background: Breast reconstruction is offered to improve quality of life for women after mastectomy for breast cancer, but information regarding the long-term patient-reported outcomes of different reconstruction procedures is currently lacking. The Brighter study aimed to evaluate long-term patient-reported outcomes after immediate breast reconstruction (IBR) in a population-based cohort.
Methods: Women who underwent mastectomy with IBR for breast cancer in England between 1 January 2008 and 31 March 2009 were identified from National Health Service Hospital Episode Statistics.
J Plast Reconstr Aesthet Surg
November 2023
Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Plastic, Reconstructive and Hand Surgery, De Boelelaan 1117, Amsterdam, the Netherlands. Electronic address:
Background: Most breast reconstructions are implant-based and can be performed either in a one-stage, direct-to-implant or in a two-stage, expander-implant-based reconstruction. The objective of this systematic review is to compare the safety and patient satisfaction of the two reconstruction approaches.
Methods: A literature search was conducted on 27 September 2022 using various databases.
Beijing Da Xue Xue Bao Yi Xue Ban
August 2023
Department of Plastic Surgery, Peking University Third Hospital, Beijing 100191, China.
Objective: To investigate the choice of immediate breast reconstructive methods and asso-ciated outcomes after modified radical mastectomy.
Methods: Retrospective analysis of patients undergoing immediate breast reconstruction after modified radical mastectomy in Peking University Third Hospital from January 2009 to May 2019. The reconstructive methods were summarized, and the clinical outcomes and the safety of immediate breast reconstruction were evaluated.
Plast Reconstr Surg Glob Open
August 2023
Division of Plastic and Reconstructive Surgery, University of Nebraska Medical Center, Omaha, Nebr.
Unlabelled: Immediate expander/implant-based breast reconstruction after mastectomy has become more sought after by patients. Although many patients choose this technique due to good aesthetic outcomes, lack of donor site morbidity, and shorter procedure times, it is not without complications. The most reported complications include seroma, infection, hematoma, mastectomy flap necrosis, wound dehiscence, and implant exposure, with an overall complication rate as high as 45%.
View Article and Find Full Text PDFAnn Surg Oncol
October 2023
Department of Anesthesia, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
Background: Ultrasound-guided pectoralis muscle blocks (PECS I/II) are well established for postoperative pain control after mastectomy with reconstruction. However, optimal timing is unclear. We conducted a randomized controlled single-blinded single-institution trial comparing outcomes of block performed pre-incision versus post-mastectomy.
View Article and Find Full Text PDFBackground: Mastectomy skin flap necrosis (MSFN) is a common complication following mastectomy that causes significant distress to patients and physicians and also compromises oncologic, surgical, and quality-of-life outcomes.
Objectives: We sought to investigate the long-term outcomes of MSFN following implant-based reconstruction (IBR) and determine the rates and predictors of post-MSFN complications.
Methods: This was a 20-year analysis of consecutive adult (>18 years) patients who developed MSFN following mastectomy and IBR from January 2001 to January 2021.
Aesthetic Plast Surg
May 2024
Department of Medical Cosmetology, Surgery, Hebei Province General Hospital, 348, West He-Ping Road, Shijiazhuang, 050051, Hebei Province, People's Republic of China.
Background: It is still a controversial debate that which type of immediate breast reconstruction should be operated on breast cancer patients in the setting of postmastectomy radiotherapy. This meta-analysis compared incidence of complications requiring reoperation (CRR), reconstruction failure (RF) and patient-reported outcome between immediate autologous breast reconstruction (ABR) and immediate implant-based breast reconstruction (IBBR), tissue expander/implant reconstruction mostly, in the setting of postmastectomy radiotherapy.
Methods: Systematic and thorough research was conducted to search for studies published before August 1, 2022, by using three online databases.
Healthcare (Basel)
June 2023
Plastic and Reconstructive Surgery Unit, Department of Surgical, Oncological and Oral Sciences (Di.Chir.On.S.), University of Palermo, Via del Vespro 129, 90127 Palermo, Italy.
Br J Surg
August 2023
Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Plast Surg (Oakv)
May 2023
Division of Plastic Surgery, Department of Surgery, University of Louisville, KY, USA.
The increasing prevalence of obesity in patients with breast cancer has prompted a reappraisal of the role of the latissimus dorsi flap (LDF) in breast reconstruction. Although the reliability of this flap in obese patients is well-documented, it is unclear whether sufficient volume can be achieved through a purely autologous reconstruction (eg, extended harvest of the subfascial fat layer). Additionally, the traditional combined autologous and prosthetic approach (LDF + expander/implant) is subject to increased implant-related complication rates related to flap thickness in obese patients.
View Article and Find Full Text PDFAnn Transl Med
March 2023
Department of Plastic Surgery, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Surg Today
August 2023
Department of Breast Surgery, Kyoto Miniren Chuo Hospital, Kyoto, Japan.
Purpose: Chronic pain following breast surgery is a concern for breast cancer survivors; however, few studies have investigated the localization of persistent postoperative pain. We conducted this study to identify the location of pain following breast reconstruction.
Methods: A total of 213 Japanese women undergoing mastectomy only or breast reconstruction with a tissue expander/implant (TE/Imp) or a deep inferior epigastric perforator (DIEP) flap were enrolled in the study.
Eur J Surg Oncol
July 2023
Department of Plastic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, South Korea. Electronic address:
Background: Whether the breast reconstruction modality could influence the long-term development of post-mastectomy lymphedema has been little investigated. The present study aimed to evaluate the potential association of the breast reconstruction method with the incidence of lymphedema over an extended follow-up period.
Methods: Patients with breast cancer who underwent immediate reconstruction from 2008 to 2014 were reviewed.
Aesthetic Plast Surg
August 2023
Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 33 Badachu Road, Shijingshan, Beijing, 100144, China.
Sci Rep
March 2023
Department of Plastic Surgery, Samsung Medical Center, Sungkyunkwan University of Medicine, 81 Irwon-Ro, Gangnam-Gu, Seoul, 06351, South Korea.
Two-stage tissue expander/implant (TE/I) and deep inferior epigastric perforator (DIEP) flaps are the two main pillars of breast reconstruction. This study aimed to conduct a longitudinal analysis of long-term outcomes after immediate DIEP- and TE/I-based reconstruction. This retrospective cohort study included patients with breast cancer who underwent immediate DIEP- or TE/I-based reconstruction between 2012 and 2017.
View Article and Find Full Text PDF